tradingkey.logo

China SXT Pharmaceuticals Inc

SXTC

1.630USD

-0.070-4.12%
Market hours ETQuotes delayed by 15 min
22.43MMarket Cap
--P/E TTM

China SXT Pharmaceuticals Inc

1.630

-0.070-4.12%
More Details of China SXT Pharmaceuticals Inc Company
China SXT Pharmaceuticals Inc is a China-based pharmaceutical company that focuses on the research, development, manufacture, marketing and sales of Traditional Chinese Medicine Pieces (TCMP). The Company develops, manufactures and sells three types of TCMP products: advanced TCMP, fine TCMP and regular TCMP, and TCM Homologous Supplements (TCMHS) products. The Company sells its TCMP products under three brand names such as Suxuangtang, Hui Chun Tang and Tong Ren Tang. Most of its products are sold on a prescription basis across China.
Company Info
Ticker SymbolSXTC
Company nameChina SXT Pharmaceuticals Inc
IPO dateJan 04, 2019
CEOMr. Lim Sze (Simon) Beng
Number of employees- -
Security typeOrdinary Share
Fiscal year-endJan 04
Address178 Taidong Road North
CityTAIZHOU
Stock exchangeNASDAQ Capital Market Consolidated
CountryChina
Postal code225300
Phone8652386298290
Websitehttps://www.sxtchina.com/
Ticker SymbolSXTC
IPO dateJan 04, 2019
CEOMr. Lim Sze (Simon) Beng
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Feng Zhou
Mr. Feng Zhou
Co-Chief Executive Officer, Director
Co-Chief Executive Officer, Director
532.00
-94.18%
Mr. Lim Sze (Simon) Beng
Mr. Lim Sze (Simon) Beng
Co-Chief Executive Officer
Co-Chief Executive Officer
--
--
Mr. Xiaodong Pan
Mr. Xiaodong Pan
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Jun Zheng
Mr. Jun Zheng
Director
Director
--
--
Mr. Xiaodong Ji
Mr. Xiaodong Ji
Independent Director
Independent Director
--
--
Mr. Tong Liu
Mr. Tong Liu
Independent Director
Independent Director
--
--
Mr. Lip Chee Yong
Mr. Lip Chee Yong
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Feng Zhou
Mr. Feng Zhou
Co-Chief Executive Officer, Director
Co-Chief Executive Officer, Director
532.00
-94.18%
Mr. Lim Sze (Simon) Beng
Mr. Lim Sze (Simon) Beng
Co-Chief Executive Officer
Co-Chief Executive Officer
--
--
Mr. Xiaodong Pan
Mr. Xiaodong Pan
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Jun Zheng
Mr. Jun Zheng
Director
Director
--
--
Mr. Xiaodong Ji
Mr. Xiaodong Ji
Independent Director
Independent Director
--
--
Mr. Tong Liu
Mr. Tong Liu
Independent Director
Independent Director
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Advanced TCMP
946.01K
49.05%
Regular TCMP
945.00K
49.00%
TCMHS
24.17K
1.25%
Others
13.15K
0.68%
Fine TCMP
166.00
0.01%
By RegionUSD
Name
Revenue
Proportion
People's Republic of China
1.93M
100.00%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Advanced TCMP
946.01K
49.05%
Regular TCMP
945.00K
49.00%
TCMHS
24.17K
1.25%
Others
13.15K
0.68%
Fine TCMP
166.00
0.01%
Shareholding Stats
Updated: Mon, Mar 10
Updated: Mon, Mar 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholder Types
Shareholders
Proportion
Individual Investor
0.01%
Other
99.99%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
20
28.22K
0.02%
-47.80K
2025Q1
20
28.22K
0.02%
-47.80K
2024Q4
22
74.93K
15.02%
+42.94K
2024Q3
24
33.98K
13.64%
+10.51K
2024Q2
21
35.50K
15.27%
+22.93K
2024Q1
24
15.92K
23.88%
+2.99K
2023Q4
23
15.02K
23.00%
+2.57K
2023Q3
23
16.29K
24.79%
+5.61K
2023Q2
20
14.62K
58.36%
+11.76K
2023Q1
21
15.07K
59.15%
+12.43K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Forsakringsaktiebolaget Skadinviska Enskilda
5.63K
0%
+1.79K
+46.68%
Aug 07, 2024
UBS Financial Services, Inc.
5.27K
0%
+5.27K
+526900.00%
Mar 31, 2025
Zhou (Feng)
9.15K
0.01%
+8.62K
+1622.41%
Jun 20, 2024
BMO Nesbitt Burns Inc.
--
0%
-1.25K
-100.00%
Mar 31, 2025
Acadian Asset Management LLC
48.00
0%
+1.00
+2.13%
Mar 31, 2025
Banque Cantonale Vaudoise
--
0%
--
--
Mar 31, 2024
Qube Research & Technologies Ltd
--
0%
-38.00
-100.00%
Sep 30, 2024
Level Four Advisory Services, LLC
--
0%
-214.00
-100.00%
Dec 31, 2023
HRT Financial LP
--
0%
-243.00
-100.00%
Dec 31, 2023
Virtu Americas LLC
--
0%
-3.95K
-100.00%
Sep 30, 2024
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Feb 21, 2025
Merger
8<1
Feb 21, 2025
Merger
8<1
Feb 21, 2025
Merger
8<1
Feb 21, 2025
Merger
8<1
Oct 04, 2023
Merger
25<1
Oct 04, 2023
Merger
25<1
Date
Type
Ratio
Feb 21, 2025
Merger
8<1
Feb 21, 2025
Merger
8<1
Feb 21, 2025
Merger
8<1
Feb 21, 2025
Merger
8<1
Oct 04, 2023
Merger
25<1
Oct 04, 2023
Merger
25<1
Oct 04, 2023
Merger
25<1
Oct 04, 2023
Merger
25<1
May 18, 2022
Merger
20<1
May 18, 2022
Merger
20<1
View more
KeyAI